HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenhao Ge Selected Research

succinoglycan

2/2022Dietary Succinoglycan Riclin Improves Glycemia Control in Mice with Type 2 Diabetes.
3/2021Anti-tumor activity and immunogenicity of a succinoglycan riclin.
12/2019Oral Administration of Succinoglycan Riclin Improves Diet-Induced Hypercholesterolemia in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenhao Ge Research Topics

Disease

6Neoplasms (Cancer)
11/2021 - 01/2019
4Type 2 Diabetes Mellitus (MODY)
02/2022 - 01/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 10/2019
2Insulin Resistance
02/2022 - 01/2020
2Obesity
01/2020 - 11/2019
1Bacterial Infections (Bacterial Infection)
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Inflammation (Inflammations)
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
11/2021
1Hypothermia
10/2021
1Sarcoma (Soft Tissue Sarcoma)
03/2021
1Sarcoma 180
03/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Reperfusion Injury
01/2021
1Hepatitis
08/2020
1Infections
04/2020
1Hypercholesterolemia
12/2019
1Vitamin A Deficiency
11/2019
1Hemolysis
01/2019
1Hyperglycemia
01/2019
1Body Weight (Weight, Body)
01/2019
1Glucose Intolerance
01/2019
1Mucositis
01/2019
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2018

Drug/Important Bio-Agent (IBA)

3succinoglycanIBA
02/2022 - 12/2019
3Adenine NucleotidesIBA
01/2021 - 01/2019
2Streptozocin (Streptozotocin)FDA Link
02/2022 - 11/2019
2pancreatic lipase related protein 2IBA
01/2022 - 08/2020
2salecanIBA
04/2020 - 01/2019
2Adenosine (Adenocard)FDA LinkGeneric
01/2020 - 01/2019
1Blood Glucose (Blood Sugar)IBA
02/2022
1NanogelsIBA
01/2022
1CollagenIBA
01/2022
1SilverIBA
01/2022
1Polysaccharides (Glycans)IBA
01/2022
1Circular RNAIBA
11/2021
1CDC2 Protein Kinase (Protein p34cdc2)IBA
11/2021
1Adenosine Triphosphate (ATP)IBA
10/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2021
1Immunomodulating AgentsIBA
08/2020
1Transaminases (Aminotransferases)IBA
08/2020
1beta-GlucansIBA
04/2020
1GemcitabineFDA Link
01/2020
1CholesterolIBA
12/2019
1Food Additives (Food Additive)IBA
12/2019
1EnzymesIBA
11/2019
1Excipients (Suspending Agents)IBA
11/2019
1Irinotecan (Camptosar)FDA LinkGeneric
11/2019
1Carboxylesterase (Hydrolase S)IBA
11/2019
1Therapeutic UsesIBA
11/2019
1ProdrugsIBA
11/2019
1Pharmaceutical PreparationsIBA
11/2019
1HydrolasesIBA
11/2019
1Pathogen-Associated Molecular Pattern MoleculesIBA
11/2019
1Vitamin A (Retinol)FDA LinkGeneric
11/2019
1GSK343IBA
10/2019
1Enhancer of Zeste Homolog 2 ProteinIBA
10/2019
1purineIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Nonesterified Fatty Acids (NEFA)IBA
01/2019
1Methotrexate (Mexate)FDA LinkGeneric
01/2019
1AntioxidantsIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Monomeric GTP-Binding ProteinsIBA
01/2019
1NucleotidesIBA
01/2019
1lanreotide (Somatuline)FDA Link
01/2018
1TOR Serine-Threonine KinasesIBA
01/2018
1EverolimusFDA Link
01/2018
1Octreotide (Sandostatin)FDA LinkGeneric
01/2018
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2018
1pasireotideIBA
01/2018
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2018

Therapy/Procedure

1Glycemic Control
02/2022
1Therapeutics
01/2021
1Intravenous Injections
01/2021
1Drug Therapy (Chemotherapy)
01/2020
1Oral Administration
12/2019
1Intraperitoneal Injections
01/2019